01749oam 2200421 a 450 991070319180332120110504083633.0(CKB)3460000000109354(OCoLC)704281464(EXLCZ)99346000000010935420110228d2011 ua 0engurbn|||||||||txtrdacontentcrdamediacrrdacarrierFood and Drug Administration's review process for products to treat rare diseases and neglected tropical diseases[electronic resource] hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eleventh Congress, second session, special hearing, June 23, 2010, Washington, D.CWashington :U.S. G.P.O.,2011.1 online resource (iii, 58 pages) illustrationsS. hrg. ;111-841Title from title screen (viewed on Feb. 28, 2011).Includes bibliographical references.Food and Drug Administration's review process for products to treat rare diseases and neglected tropical diseases Rare diseasesTreatmentTropical medicineOrphan drugsUnited StatesDrug developmentGovernment policyUnited StatesRare diseasesTreatment.Tropical medicine.Orphan drugsDrug developmentGovernment policyGPOGPOGPOBOOK9910703191803321Food and Drug Administration's review process for products to treat rare diseases and neglected tropical diseases3464401UNINA